About

Using generative biology and chemistry, we are revolutionizing the speed and accuracy of how medicine is created.

Our HyperloopTM Platform combines deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure to create candidate-ready compounds with unprecedented speed.

Our Core Values:

  • Urgency: We move swiftly and purposefully to address critical unmet patient needs.
  • Resilience: We persist in the face of challenges, turning setbacks into opportunities.
  • Collaboration: We build strong partnerships and value diverse perspectives.
  • Transparency: We build trust through openness, directness, and accountability.
  • Compassion: We lead with empathy, always keeping patients at the heart of our mission.

Our Team

Staff

Principal Scientist, Biology
Chief Scientific Officer
Sr. Scientist, Biology
Associate Director, Program Management
Senior Research Associate, Biology
Sr. Scientist, Lead Generation
VP, Head of LEADs
Sr. Scientist, Protein Design & Structure

Cony D’Cruz

CEO
Principal Scientist, Medicinal Chemistry
VP, Head of IDEAs
Sr. Scientist, Lead Generation
Scientist II, Biology
Accounting Manager
Associate Director, Computational Chemistry
Lab Technician, Protein Design & Structure
Sr. Scientist, Lead Generation
Associate Director, Program Management
Sr. Director, Head of Lead Generation
Principal Scientist, Discovery Biology
Senior Research Associate, Biology
Lab Operations Manager
SVP, Finance
Executive Director, Clinical Development & Operations
Office Manager
Chief of Staff, Head of Program and Alliance Management
Director, Business Operations
Principal Scientist, Lead Generation
Sr. Director, Head of Computation
Director, Medicinal Chemistry
Senior Scientist, Compound Management
Principal Scientist, Exploratory Biology
Senior Research Associate, Biology
Associate Director, Protein Design & Structure
Associate Director, Computational Chemistry
Research Associate, Biology
Principal Scientist, Computational Chemistry
Chief Financial Officer
Associate Director, Medicinal Chemistry
Director, Computational Chemistry
Associate Director, Patent Agent
Engineer II, Machine Learning
Principal Scientist, Medicinal Chemistry
SVP, Business Development and Operations
Associate Director, Pharmacology
Associate Vice President, Toxicology
Specialist II, Business Operations
Scientist, Protein Design & Structure
VP, Head of BRIDGE
Sr. Lab Scientist, Biology
Principal Scientist, Biology
Director, Head of Biology

Yung-Chi Huang

Sr. Scientist, Biology
Senior Engineer, Machine Learning

Join Our Team

Join us to accelerate new possibilities in drug discovery.

Scientific Advisory Board

Carrie Haskell-Luevano, PhD

Philip S. Portoghese Endowed Chair in Chemical Neuroscience
Institute for Translational Neuroscience Scholar
Department of Medicinal Chemistry, University Of Minnesota
Trilligant LLC, Founder
Professor Emeritus, University of Pennsylvania
Chief Research & Development Officer, BioCryst Pharmaceuticals
Professor, Department of Pharmacology
University of North Carolina- School of Medicine

Board of Directors

Nandita Shangari

Managing Director- RA Capital Management

Cony D’Cruz

CEO - Superluminal Medicines
Partner & Head of Research - Catalio Capital Management, LP
Managing Director- Insight Partners

Explore More

Science

Our HyperloopTM Platform unites novel structure-based drug discovery with AI-driven computational approaches and experimental readouts to discover and validate small molecule therapeutics.

Pipeline

With an initial focus on GPCRs, our pipeline combines scientific ingenuity with patient-focused precision, developing next-generation treatments for cardiometabolic diseases.